Digital Library
Close Browse articles from a journal
 
<< previous    next >>
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
           All articles of the corresponding issues
                                       Details for article 22 of 23 found articles
 
 
  Urinary Homocysteic Acid Levels Correlate with Mini-Mental State Examination Scores in Alzheimer's Disease Patients
 
 
Title: Urinary Homocysteic Acid Levels Correlate with Mini-Mental State Examination Scores in Alzheimer's Disease Patients
Author: Hasegawa, Tohru
Ichiba, Masayoshi
Matsumoto, Shin-ei
Kasanuki, Koji
Hatano, Taku
Fujishiro, Hiroshige
Iseki, Eizo
Hattori, Nobutaka
Yamada, Tatsuo
Tabira, Takeshi
Appeared in: Journal of Alzheimer's disease
Paging: Volume 31 (2012) nr. 1 pages 59-64
Year: 2012-04-18
Contents: Homocysteic acid (HA) has been suggested as a pathogen in a mouse model of Alzheimer's disease (AD), 3xTg-AD. However, it is not established whether HA is involved in humans. We investigated the relationship between urinary HA levels and Mini-Mental State Examination (MMSE) scores in AD patients (n = 70) and non-AD controls (n = 34). We found a positive, statistically significant relationship between the two variables (the urinary HA level and MMSE score) (r = 0.31, p = 0.0008, n = 70). This relationship was stronger in females than males (r = 0.43, p = 0.005, n = 44 in females; r = 0.48, p = 0.02, n = 22 in males). The urinary HA levels were significantly different in AD patients than controls (AD: 8.7 ± 7.5, n = 70; non-dementia control: 13.3 ± 9.4, n = 34, p < 0.01). In addition, aging and smoking were found as lowering factors for urinary HA levels. Our preliminary study showed a negative, statistically significant relationship between blood HA (micromole) and urine HA levels (r = −0.6, p = 0.007, n = 19), and between blood HA levels and MMSE scores (r = −0.79, p = 0.0000518, n = 19). On the basis of these results, we speculate that reduced urinary excretion induces elevated HA levels in blood, resulting in cognitive dysfunctions. This study also suggests that HA may be a candidate of neurotoxins for uremic encephalopathy. Since amyloid-β increases HA toxicity and HA is an agonist of N-methyl-D-aspartic acid (NMDA) receptor, we speculate that elevated blood HA affects the brain cognitive function through NMDA receptor-mediated toxicity in AD.
Publisher: IOS Press
Source file: Elektronische Wetenschappelijke Tijdschriften
 
 

                             Details for article 22 of 23 found articles
 
<< previous    next >>
 
 Koninklijke Bibliotheek - National Library of the Netherlands